Literature DB >> 2318945

Blindness impairs plasma growth hormone response to L-dopa but not to arginine.

A Bellastella1, F Parlato, A A Sinisi.   

Abstract

To investigate how blindness influences GH secretion, we studied the GH response to L-dopa and arginine in 8 blind adult males and 10 normal age-matched control males. Arginine and L-dopa tests were performed in random order at least 1 week apart at 0800 h, and plasma GH was measured by RIA. The blind subjects showed GH responses to arginine similar to those in normal subjects [peak, 22.1 +/- 1.3 vs. 20.5 +/- 1.3 micrograms/L (+/- SE)], but their GH response to L-dopa was significantly reduced [peak, 5.4 +/- 1.3 vs. 20.3 +/- 2.4 micrograms/L (+/- SE); P less than 0.01]. Because L-dopa is believed to release GH by stimulating endogenous GHRH, whereas arginine may act by suppressing endogenous somatostatin secretion, we propose that blindness may impair GH release by inhibiting GHRH secretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318945     DOI: 10.1210/jcem-70-4-856

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Light, blindness and endocrine secretions.

Authors:  A Bellastella; G Amato; A Bizzaro; C Carella; T Criscuolo; S Iorio; V I Muccitelli; G Pisano; A A Sinisi; A De Bellis
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

2.  Twenty-four hour melatonin pattern in acromegaly: effect of acute octreotide administration.

Authors:  A A Sinisi; D Pasquali; A D'Apuzzo; D Esposito; T Venditto; T Criscuolo; A De Bellis; A Bellastella
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients.

Authors:  S Willnow; W Kiess; O Butenandt; H G Dorr; A Enders; B Strasser-Vogel; J Egger; H P Schwarz
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

4.  Normal plasma insulin-like growth factor I levels and impaired final stature in adult blind subjects.

Authors:  A Bellastella; T Criscuolo; S Iorio; F Parlato; A A Sinisi; A M Sinisi; D Pasquali; G Pisano
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.